QuintilesIMS' Doug Long Discusses U.S. Pharmaceutical Outlook 1/13/2017
This year's Retail Pharmacy - Branded Rx & Vaccine EPPS featured an educational session by QuintilesIMS VP of Industry Relations Doug Long, during which he discussed trends and provided a future outlook for the pharmaceutical industry
Among the topics he discussed were:
- Growth categories
- Key industry issues
- The future of biosimilars
- Oncology
- Pharmaceutical regulations and spending
Doug Long is the Vice President of Industry Relations for QuintilesIMS, an integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles Transnational and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries.
Companies seeking to improve real-world patient outcomes through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial, bringing customers a unique opportunity to realize the full potential of innovations and advanced healthcare outcomes.
